Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myomo (MYO) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Myomo (MYO) over the last 10 years, with Q3 2025 value amounting to $12.9 million.

  • Myomo's Cash & Equivalents rose 8475.51% to $12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.9 million, marking a year-over-year increase of 8475.51%. This contributed to the annual value of $24.7 million for FY2024, which is 26015.53% up from last year.
  • According to the latest figures from Q3 2025, Myomo's Cash & Equivalents is $12.9 million, which was up 8475.51% from $15.5 million recorded in Q2 2025.
  • Myomo's 5-year Cash & Equivalents high stood at $24.7 million for Q4 2024, and its period low was $5.3 million during Q4 2022.
  • Its 5-year average for Cash & Equivalents is $11.5 million, with a median of $10.2 million in 2022.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 6556.41% in 2022, then skyrocketed by 27110.98% in 2025.
  • Over the past 5 years, Myomo's Cash & Equivalents (Quarter) stood at $15.5 million in 2021, then crashed by 65.56% to $5.3 million in 2022, then grew by 28.53% to $6.9 million in 2023, then skyrocketed by 260.16% to $24.7 million in 2024, then tumbled by 47.76% to $12.9 million in 2025.
  • Its Cash & Equivalents was $12.9 million in Q3 2025, compared to $15.5 million in Q2 2025 and $20.2 million in Q1 2025.